BLOOD COAGULATION NORMALIZER CONTAINING TCF-II AS ACTIVE INGREDIENT

摘要

Blood coagulation normalizing agents comprising effective ingredient of TCF-II. The blood coagulation normalizing agents of the present invention comprised of glycoprotein TCF-II produced by human fibroblast cells and accelerates the production of blood coagulation factor and increases platelet count to treat abnormal blood coagulation such as disseminated intravascular coagulation (DIC) and decreased platelet count caused by administration of cisplatin.